CMXI Insider Trading Activity and SEC Form 4 Filings
CMXI insider trading summary
No open-market insider purchases or sales of Cytomedix Inc (CMXI) have been reported on SEC Form 4 in the past 12 months.
Latest CMXI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 6, 2014 | Dean Tozer | Chief Commercial Officer | Buy | $12K (33,300 @ $0.36) |
| Sep 12, 2014 | Dean Tozer | Chief Commercial Officer | Buy | $18K (40,000 @ $0.45) |
| Aug 29, 2014 | Dean Tozer | Chief Commercial Officer | Buy | $14K (40,000 @ $0.35) |
| Aug 26, 2014 | Steven A Shallcross | Chief Financial Officer | Buy | $10K (27,500 @ $0.38) |
| Aug 22, 2014 | Dean Tozer | Chief Commercial Officer | Buy | $15K (38,700 @ $0.38) |
| Aug 20, 2014 | Steven A Shallcross | Chief Financial Officer | Buy | $20K (52,000 @ $0.39) |
| Aug 20, 2014 | Dean Tozer | Chief Commercial Officer | Buy | $19K (48,000 @ $0.39) |
| Aug 20, 2014 | Martin P Rosendale | Chief Executive Officer | Buy | $10K (25,000 @ $0.40) |
| May 21, 2013 | David Emerson Jorden | Director | Buy | $28K (55,000 @ $0.50) |
| May 17, 2013 | David Emerson Jorden | Director | Buy | $13K (25,000 @ $0.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.